Welcome!

News Feed Item

JSS Medical Research Inc. and Integrated Research Inc. in Montréal, Québec, Canada completes the strategic merger of the two companies to become the largest Canadian owned CRO

MONTREAL, Jan. 7, 2014 /PRNewswire/ - JSS Medical Research Inc. (JSS), a full-service international Contract Research Organization (CRO), announced today that it has completed the acquisition of Integrated Research Inc. (IRI), a Canadian CRO located in Dollard-des-Ormeaux, Quebec. The transaction results in the strategic merger of the two companies with IRI continuing to operate as a fully-owned subsidiary of JSS.

IRI was founded over two decades ago by Joanne E. Watson M.Sc. and it provides clinical research support to pharmaceutical, device, and biotechnology companies. The company's core service offering includes study start-up, project management, site management, data management, and monitoring covering a wide range of therapeutic areas. With clinical operations as its foundation, and owing to its in-depth knowledge and understanding of regulatory matters, and extensive network of experienced clinical researchers, IRI has become a leading Canadian CRO with an impeccable reputation for providing the highest quality of comprehensive and flexible study management.

JSS Medical Research was also founded approximately twenty years ago by Dr. John S. Sampalis a Clinical Epidemiologist from McGill University. Clinical Research, Medical Science, Epidemiology and Biostatistics were the cornerstones of the foundation of JSS. Clinical Operations were incorporated on the scientific foundation and hence the company evolved as a fully integrated CRO offering services that include strategic consulting, study conceptualization, study design, protocol development, execution, project management, site management, monitoring, data management, biostatistical consulting and analysis, and medical writing. The company has earned an international reputation as one of the leading scientific CROs with significant expertise in pre- and post-approval epidemiological studies.

"This is an important milestone for JSS and IRI as well as for the Canadian Industry. The merger of JSS and IRI creates a robust and stable Canadian based and owned CRO that has the critical mass, expertise and most importantly, experienced senior management that will offer highest quality services covering all of the scientific and operational aspects of clinical research. Now a local CRO will be able to provide the same services as the large multinationals, while maintaining the intimate client relationships that have contributed to our longevity and client loyalty over the last twenty years" stated Dr. John S. Sampalis, CEO and President of JSS Medical Research.

"For our international and global clients, the merger with IRI, in combination with the recent acquisition of Latam Clinical Trials, provides significant advantages. We now have augmented our operational and regulatory expertise across several jurisdictions and expanded the clinical research team to allow us to easily manage our local and international studies. In addition, our clients will benefit from our Quality Assurance Program which has been audited and tested by several of our global clients" said Ms. Stella Boukas, V.P. Clinical Operations of JSS.

"From a financial perspective, the synergies of JSS and IRI will provide our clients with a stronger CRO that can address all of their service needs with conservative costs. In the current CRO market where costs are an important second consideration for the selection of service providers, JSS-IRI will offer competitive pricing at uncompromised quality. At the same time the merger of the two companies will reduce overhead and other costs and will contribute to our continued financial stability and growth" stated Dr. Toni Rinow, CFO of JSS.

"Widespread adoption of outsourcing has changed the clinical services landscape over the past five years with strategic relationships with the 10 large CROs dominating the market. Smaller CROs have to adapt their business strategies to meet the changing needs of sponsors. JSS Medical Research has pursued its journey in becoming a niche provider in late phase studies by excelling in scientific methods for conducting research. We have gained strategic advantage as market leader in Post Marketing Observational Studies, Health Economic Outcome Research and a proven track record in medical writing, publications and presentations at scientific conferences. The merger with IRI will strengthen our position in Canada and provide the foundation for our continued expansion while at the same time enabling us to continue to deliver high quality research to our Canadian and international clients" said Dr. Sanjay Machado, Executive Director Global Business Operations of JSS.

"In an industry that is both dynamic and volatile, our growth strategy is driven by the demands and the needs of our clients. More specifically, our expansion in Latin America, which began with the acquisition of Latam and will continue with others in Chile, Argentina and Brazil, has resulted from the increasing requirements for epidemiological and post marketing studies by regional health authorities and payers in these regions. The merger with IRI has also been driven by the need for a Canadian CRO that can provide comprehensive high quality turnkey services to the Canadian Affiliates of International Pharmaceuticals and Canadian biotech companies. Integrated Research's philosophy with emphasis on high quality clinical operations governed by integrity and responsiveness to their clients was entirely compatible with the JSS Medical Research's vision" concluded Dr. Sampalis.

"The pace of growth at JSS Medical Research sees us joining a company at a very exciting time and being part of this group will enable us to better leverage our expertise, offering our local and international clients access to additional complementary services provided by senior personnel with the highest possible level of scientific expertise and knowledge in clinical trial operations," said Joanne Watson, founder and CEO of Integrated Research. "Both companies' business ethic is focused on a commitment to excellence and quality and this philosophy is only further reinforced by the combination of the two organizations."

About JSS Medical Research

JSS Medical Research is a full-service CRO with its corporate office in Montreal, Canada and a regional office in Colombia. The company offers clinical trial management services in Phase I-IV trials in a broad range of therapeutic areas and is a leader in Post-Approval Clinical Epidemiology Studies (PACES) including Post-Marketing Observational Studies, Health Outcomes Research and Health Economics. Personalized services with one-on-one client attention from experienced senior scientific and clinical teams have established JSS Medical Research as a unique niche CRO worldwide. Currently JSS Medical Research is conducting research studies in over 20 countries around the world for its clients which include the top 20 global pharmaceutical companies.

www.jssresearch.com.

About Integrated Research Inc.

Integrated Research Inc. is a Canadian contract research organization providing clinical research management services and expert assistance to pharmaceutical and biotechnology firms worldwide in the development of their therapeutic agents.  Headquartered in Montreal, its highly skilled team offers a complete range of services and guidance in Phase II, III, and IV studies, post-marketing surveillance programs, and Investigator-driven research initiatives. For over 21 years, IRI has prided itself on meeting the challenges of research by providing innovative solutions along with the flexibility and professionalism you expect when outsourcing your clinical research needs.

SOURCE JSS Medical Research Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Auditwerx will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Auditwerx specializes in SOC 1, SOC 2, and SOC 3 attestation services throughout the U.S. and Canada. As a division of Carr, Riggs & Ingram (CRI), one of the top 20 largest CPA firms nationally, you can expect the resources, skills, and experience of a much larger firm combined with the accessibility and attent...
SYS-CON Events announced today that Technologic Systems Inc., an embedded systems solutions company, will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Technologic Systems is an embedded systems company with headquarters in Fountain Hills, Arizona. They have been in business for 32 years, helping more than 8,000 OEM customers and building over a hundred COTS products that have never been discontinued. Technologic Systems’ pr...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
SYS-CON Events announced today that HTBase will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. HTBase (Gartner 2016 Cool Vendor) delivers a Composable IT infrastructure solution architected for agility and increased efficiency. It turns compute, storage, and fabric into fluid pools of resources that are easily composed and re-composed to meet each application’s needs. With HTBase, companies can quickly prov...
Imagine having the ability to leverage all of your current technology and to be able to compose it into one resource pool. Now imagine, as your business grows, not having to deploy a complete new appliance to scale your infrastructure. Also imagine a true multi-cloud capability that allows live migration without any modification between cloud environments regardless of whether that cloud is your private cloud or your public AWS, Azure or Google instance. Now think of a world that is not locked i...
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
In his session at Cloud Expo, Alan Winters, an entertainment executive/TV producer turned serial entrepreneur, will present a success story of an entrepreneur who has both suffered through and benefited from offshore development across multiple businesses: The smart choice, or how to select the right offshore development partner Warning signs, or how to minimize chances of making the wrong choice Collaboration, or how to establish the most effective work processes Budget control, or how to max...
What if you could build a web application that could support true web-scale traffic without having to ever provision or manage a single server? Sounds magical, and it is! In his session at 20th Cloud Expo, Chris Munns, Senior Developer Advocate for Serverless Applications at Amazon Web Services, will show how to build a serverless website that scales automatically using services like AWS Lambda, Amazon API Gateway, and Amazon S3. We will review several frameworks that can help you build serverle...
MongoDB Atlas leverages VPC peering for AWS, a service that allows multiple VPC networks to interact. This includes VPCs that belong to other AWS account holders. By performing cross account VPC peering, users ensure networks that host and communicate their data are secure. In his session at 20th Cloud Expo, Jay Gordon, a Developer Advocate at MongoDB, will explain how to properly architect your VPC using existing AWS tools and then peer with your MongoDB Atlas cluster. He'll discuss the secur...
Buzzword alert: Microservices and IoT at a DevOps conference? What could possibly go wrong? In this Power Panel at DevOps Summit, moderated by Jason Bloomberg, the leading expert on architecting agility for the enterprise and president of Intellyx, panelists peeled away the buzz and discuss the important architectural principles behind implementing IoT solutions for the enterprise. As remote IoT devices and sensors become increasingly intelligent, they become part of our distributed cloud enviro...
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
SYS-CON Events announced today that Infranics will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Since 2000, Infranics has developed SysMaster Suite, which is required for the stable and efficient management of ICT infrastructure. The ICT management solution developed and provided by Infranics continues to add intelligence to the ICT infrastructure through the IMC (Infra Management Cycle) based on mathemat...
Most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes a lot of work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reduction in cost...
@DevOpsSummit has been named the ‘Top DevOps Influencer' by iTrend. iTrend processes millions of conversations, tweets, interactions, news articles, press releases, blog posts - and extract meaning form them and analyzes mobile and desktop software platforms used to communicate, various metadata (such as geo location), and automation tools. In overall placement, @DevOpsSummit ranked as the number one ‘DevOps Influencer' followed by @CloudExpo at third, and @MicroservicesE at 24th.
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...